InspireMD

Related Content

Day-long summit organized by CRF and Fogarty Innovation will convene clinicians, entrepreneurs, industry, and government stakeholders for education, collaboration, and real-world insight
News | Stents Carotid
InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

June 26, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home June 26, 2023
arrow
CGuard Carotid Stent
News | Stents Carotid
InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial
February 28, 2022 – InspireMD, Inc., a global developer of the CGuard Embolic Prevention Stent System (EPS) device for ...
Home February 28, 2022
arrow
The InspireMD CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid artery disease (CAD) and stroke prevention has received reimbursement in France from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the French National Authority for Health (HAS).
News | Stents Carotid
CGuard Embolic Prevention Carotid Stent Receives French Reimbursement Approval 

October 15, 2021 — The InspireMD CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid artery ...

Home October 15, 2021
arrow
InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.
News | Embolic Protection Devices
CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger

February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke ...

Home February 09, 2021
arrow
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid
Study Supports Clinical Benefit, Utility of CGuard Embolic Prevention System

November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a new ...

Home November 18, 2016
arrow
InspireMD, CGuard, PARADIGM study, EuroPCR 2015, Musialek
News | Embolic Protection Devices
InspireMD's CGuard Highlighted at EuroPCR 2015

June 23, 2015 - InspireMD Inc. announced that its CGuard embolic prevention system reported positive results in the ...

Home June 23, 2015
arrow
InspireMD, MGuard, CGuard, drug-eluting stent, MASTER II, CARENET, trials
News
InspireMD Announces Clinical Data from MASTER and CARENET Trials

January 5, 2015 — InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the ...

Home January 05, 2015
arrow
News
InspireMD Announces Recall of its MGuard Prime EPS

May 9, 2014 — InspireMD Inc. initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS ...

Home May 09, 2014
arrow
Feature
First Patient Enrolled in Trial Testing Combined Stent/Embolic Protection Device

March 26, 2014 — Inspire MD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using ...

Home March 26, 2014
arrow
clinical trial study stents cath lab mguard inspiremd
News
InspireMD's MGuard Stent Shows Lower Mortality Rate in STEMI Patients at 12 Months Compared to Control Group

November 13, 2013 — InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard ...

Home November 13, 2013
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now